PWMG
TEVA icon

Private Wealth Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Private Wealth Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17K Hold
64
– – ﹤0.01% 1140
2026
Q1 		$1.93K Buy
+64
New +$2.06K ﹤0.01% 1096

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Private Wealth Management Group's TEVA Position: Q2 2026 in Review

Private Wealth Management Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 64 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Private Wealth Management Group first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Private Wealth Management Group held 64 shares of Teva Pharmaceuticals worth $2.17K as of Q2 2026.
  • Private Wealth Management Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1140 holding.
  • Private Wealth Management Group first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.